NEFL and Alzheimer disease: Also notable was the observation that sEVL1CAM had significantly decreased NfL levels in the MCI group following MMKD intervention, even though prior CSF data was unrevealing.17 These results suggest that sEVL1CAM in plasma could provide valuable information about the changes in the key Alzheimer’s disease biomarkers.